# E-DRUG: Conference announcement

**URL:** <https://talk.edrugplus.org/t/e-drug-conference-announcement/2569>\
**Category:** e-drug\
**Created:** [May 7, 1998, 7:05am UTC](https://talk.edrugplus.org/t/e-drug-conference-announcement/2569 "1998-05-07T07:05:53Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Hana\_Mullerova](https://avatars.discourse-cdn.com/v4/letter/h/b9bd4f/32.png) [@Hana\_Mullerova](https://talk.edrugplus.org/u/Hana_Mullerova)\
**Post date:** [May 7, 1998, 7:05am UTC](https://talk.edrugplus.org/t/e-drug-conference-announcement/2569/1 "1998-05-07T07:05:53Z")

</div>

E-drug: Conference announcement  
---------------------------------------------

Dear listmembers,

Here is the final announcement of the conference on ethics and  
economics in pharmacotherapy.

Hana Muellerova, PhD  
Dept. Social&Clinical Pharmacy  
Charles University  
Hradec Kralove 50005  
Czech Republic  
fax - +420/49/5210002  
e-mail: mulleroh@faf.cuni.cz

ETHICAL AND ECONOMICAL ASPECTS OF  
PHARMACOTHERAPY  
June, 4 - 6, 1998 in Hradec Kr�lov�, Czech Republic

Programme  
4.6.1998  
8.30 Opening (J.Vlcek, E.Kvasnickov�, L.Pr�znovcov�; J.  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kouteck )  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lectures I - chairmen: R. Dessing, L. Pr�znovcov�,  
9.00 Merrills J (UK): An introduction to ethics and economics  
9.30 Kouteck J (Czech Republic): Ethical problems from the  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;point of view of physicians  
9.55 Sado (F): Clinical trials  
10.20 Ch. Byk (France - CIOMS)): Drugs and the European  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legislation Policy: developing the market and safety  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;needed in public health  
11.45 Coffee break  
12.00 J. Payn (Czech Republic): Informed consent: Its structure  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and role in modern medicine  
12.25 A. Edgar (UK) :"Teaching of ethics, focusing on the  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patient"  
12.50 Lunch Discussion  
14.00 Workshops 1 - 6  
16.00 Coffee break - poster discussion  
16.30 Lectures II - chairmen: B. Leufkens, J. Netocn  
16.35 R. Walker (UK): Can we afford the medicines we need -  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an ethical dilemma  
16.55 CB Claesson (Sweden): Drug choice and ethical dilemma  
16.40 A. Hartzema (USA North Caroline): Practice guidelines:  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the economics of evidence based clinical decisions.  
17.10 Discussion  
17.30 Gottler M., Scheenweiss S., Hasfors J (Germany )\> Cost  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and preventability of adverse drug reactions leading to  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;hospital admissions  
17.45 Bovy K., R. Vanden Stichele, Bogaert M.(Belgium)  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Management of severe pediatric cancer pain in Flemish  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;University hospitals  
18.00 Prymula R (CZ)  
20.00 Party

5.6.1998  
9.00 Lectures III - chairmen B. Hartzema, J. Vleek, S. Salek  
9.00 B. Leufkens (The Netherlands): 'The interplay between  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;drug and patient / factors in evaluating patient outcomes  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of drug therapy'?  
9.25 L.Bootman (USA): Economics of drug related morbidity  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and Mortality in ambulatory, acute care and long term  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;care settings  
9.50 S.Salek (UK) "Health-Related Quality of Life (HRQoL)  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and Pharmacotherapeutic outcomes: Practical and  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Methodological Issues for Teaching and Research"  
10.15 Coffee break - poster discussion  
10.45 R. Dessing (The Netherlands) - Ethics in pharmacy -  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;what is the reality  
11.15 M.Schaefer (Germany): Quality of Life in Pharmaceutical  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Care  
11.30 Discussion of last two lectures  
11.40 J.Lilja (Finland) : Ethical values in pharmacotherapy  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and pharmacoeconomics -With examples from the field  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of psychotropics  
12.05 G. Carstens (Germany)): Economical and ethical aspects  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of cancer therapy  
12.30 Reinstein JA (UK): Ethical promotion and advertising -  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;what does it mean and how can it be controlled?  
13.00 Lunch  
14.15 Workshops 1 - 6  
16.00 Coffee break  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lecture IV - chairman: R. Walker  
16.30 J. Cvihovec, J. Blaho : Ethical and economical problems  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of drug categorisation for drug reimbursement  
17.20 Round table discussion  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;chair - R. Walker, J Cvihovec (authorities), A. Hartzema  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;scientist); Reinstein JA, (industry), R. Dessing  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(pharmacist), C. Anderson (inter-professional relations)  
18.20 Conclusion of symposium  
20.30 Farewell dinner in Alexandria

1/ R. Walker: Managing the entry of new drugs  
2/ A. Edgard; S. Salek: Ethical aspects of QALYs  
3/ L. Bootman: Pharmacoeconomic education for  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pharmacists.  
4/ G. Carstens: Economical and ethical aspects of cancer  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;therapy  
5/ A. Hartzema: Health related-QoL instrumentation.  
6/ C. Anderson (UK): Interface between physicians and  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pharmacists

Third day - 6.6.1998 Praha - Carolinum sight seeing  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18.00 dinner

Contacts  
Detailed information (including full programme) is available on  
home page: [http://www.faf.cuni.cz/](http://www.faf.cuni.cz/)

Symposium Secretariat - registration:  
Ethical and Economical Aspects of Pharmacotherapy  
Czech Medical Association J. E. Purkyn�  
P. O. Box 88, Sokolsk� 31, CZ - 120 26 Prague 2  
Czech Republic  
Phone: + 420 2 297 271, + 420 2 2491 5195  
Fax: + 420 2 294 610, + 420 2 2421 6836  
E-mail: lon@czechmed.anet.cz

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registration Fees:  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Late (after May 1)  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Full participant 450 DM  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Student 200 DM  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accompanying person 150 DM  
--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.